Urinary Tract Cancer Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Urinary Tract Cancer Market
Urinary Tract Cancer Market: By Type (Squamous Cell Carcinoma, Transitional Cell Carcinoma, Others); By Diagnostic Tools (Biopsy, Cystoscopy, Others); By Treatment (Biological Therapy, Surgical Treatment, Others) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0708
Updated Date: 31 May, 2018  

1. Urinary Tract Cancer Market – Overview
2. Executive Summary 
3. Urinary Tract Cancer Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Urinary Tract Cancer Market– Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance medicine and diagnostic tools
      4.1.2. Growing prevalence of a sedentary lifestyle
   4.2. Restraints
      4.2.1. Higher cost of research and development 
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Urinary Tract Cancer Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Urinary Tract Cancer Market, By Type
   6.1. Squamous Cell Carcinoma
   6.2. Transitional Cell Carcinoma
   6.3. Adenocarcinoma
   6.4. Others
7. Urinary Tract Cancer Market, By Diagnostic Tests
   7.1. Biopsy
   7.2. Cystoscopy
   7.3. Urine Cytology
   7.4. Imaging Test
   7.5. Others
8. Urinary Tract Cancer Market, By Treatment 
   8.1. Biological Therapy
   8.2. Surgical Treatment
   8.3. Radiation Therapy
   8.4. Chemotherapy
   8.5. Others
9. Urinary Tract Cancer Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America 
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Urinary Tract Cancer – Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. Bristol-Myers Squibb Company
   11.2. F. Hoffmann-La Roche Ltd.
   11.3. Kyowa Hakko Kirin Co., Ltd.
   11.4. Boehringer Ingelheim GmbH
   11.5. Eli Lilly and Company
   11.6. Novartis AG
   11.7. IkerChem S.L.
   11.8. GlaxoSmithKline plc
   11.9. Genzyme Corporation
   11.10. Medical Enzymes AG
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll